Hofmann C, Oslapas R, Nayyar R, Paloyan E
J Natl Cancer Inst. 1986 Jul;77(1):253-60.
When male Long-Evans rats at age 8 weeks were radiation treated (40 microCi Na131I), thyroid follicular adenomas and carcinomas were observed at age 24 months with a high incidence of 94%. Castration of males prior to irradiation significantly reduced this tumor incidence to 60%. When testosterone (T) was replaced in castrated, irradiated male rats, differentially increased incidences of thyroid tumors occurred, depending on the time interval for hormone replacement. Immediate (age 2-6 mo) or early (age 6-12 mo) T replacement at approximate physiologic levels led to thyroid follicular tumor incidences of 100 and 82%, respectively, whereas intermediate (12-18 mo) or late (18-24 mo) T treatment led to only 70 and 73% incidences, respectively. Continuous T replacement (2-24 mo) in castrated irradiated male rats raised thyroid tumor incidence to 100%. Since elevated thyroid-stimulating hormone (TSH) is a reported requisite for development of radiation-associated thyroid tumors, the effects of T on serum TSH levels were examined. Mean serum TSH values in all irradiated animal groups were significantly elevated above age-matched nonirradiated animals at 6, 12, 18, and 24 months. Serum TSH levels were higher in continuous T-replaced irradiated castrates than in intact, irradiated males, whereas such intact male TSH levels were greater than those for irradiated castrates without T treatment. Interval T replacement in castrated male rats was generally associated with increased serum TSH levels during the treatment interval and with lowered TSH levels after discontinuation of T treatment, particularly in irradiated rats. However, when irradiated, castrated males received late T replacement (age 18-24 mo), there was no elevation of TSH at the end of the treatment interval. Thus an indirect effect of T via early stimulation of TSH may be at least partly responsible for the high incidence of irradiation-induced thyroid tumors in rats.
8周龄的雄性Long-Evans大鼠接受放射性治疗(40微居里的Na131I)后,在24月龄时观察到甲状腺滤泡腺瘤和癌,发病率高达94%。照射前对雄性大鼠进行去势可将肿瘤发病率显著降低至60%。当给去势且接受照射的雄性大鼠补充睾酮(T)时,甲状腺肿瘤的发病率会根据激素替代的时间间隔而出现不同程度的增加。在大约生理水平下立即(2 - 6月龄)或早期(6 - 12月龄)进行T替代,甲状腺滤泡肿瘤的发病率分别为100%和82%,而中期(12 - 18月龄)或晚期(18 - 24月龄)进行T治疗时,发病率分别仅为70%和73%。在去势且接受照射的雄性大鼠中持续进行T替代(2 - 24月龄)会使甲状腺肿瘤发病率升至100%。由于甲状腺刺激激素(TSH)升高是辐射相关甲状腺肿瘤发生的一个必要条件,因此研究了T对血清TSH水平的影响。在6、12、18和24个月时,所有接受照射的动物组的平均血清TSH值均显著高于年龄匹配的未照射动物。持续接受T替代的照射去势大鼠的血清TSH水平高于完整的照射雄性大鼠,而完整雄性大鼠中的TSH水平高于未接受T治疗的照射去势大鼠。去势雄性大鼠进行间歇性T替代时,在治疗期间血清TSH水平通常会升高,而在停止T治疗后TSH水平会降低,尤其是在照射大鼠中。然而,当接受照射的去势雄性大鼠在晚期(18 - 24月龄)进行T替代时,在治疗期结束时TSH并未升高。因此,T通过早期刺激TSH产生的间接作用可能至少部分导致了大鼠中辐射诱导的甲状腺肿瘤的高发病率。